Prognostic Role of NT-proBNP for in-Hospital and 1-Year Mortality in Patients with Acute Exacerbations of COPD

References

• VogelmeierCF, CrinerGJ, MartinezFJ, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report: GOLD executive summary. Arch Bronconeumol. 2017;53(3):128–149. doi:10.1016/j.arbres.2017.02.00128274597
   PubMed Web of Science ®Google Scholar
• SorianoJB, AbajobirAA, AbateKH, et al. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Respir Med. 2017;5(9):691–706. doi:10.1016/S2213-2600(17)30293-X28822787
   PubMed Web of Science ®Google Scholar
• WatzH, WaschkiB, MeyerT, et al. Decreasing cardiac chamber sizes and associated heart dysfunction in COPD: role of hyperinflation. Chest. 2010;138(1):32–38. doi:10.1378/chest.09-281020190002
   PubMed Web of Science ®Google Scholar
• BhattSP, DransfieldMT. Chronic obstructive pulmonary disease and cardiovascular disease. Transl Res. 2013;162(4):237–251. doi:10.1016/j.trsl.2013.05.00123727296
   PubMed Web of Science ®Google Scholar
• FabbriLM, LuppiF, BegheB, RabeKF. Complex chronic comorbidities of COPD. Eur Respir J. 2008;31(1):204–212. doi:10.1183/09031936.0011430718166598
   PubMed Web of Science ®Google Scholar
• PonikowskiP, VoorsAA, AnkerSD, et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Rev Esp Cardiol (Engl Ed). 2016;69(12):1167.27894487
   PubMed Web of Science ®Google Scholar
• YancyCW, JessupM, BozkurtB, et al. 2017 ACC/AHA/HFSA focused update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. J Am Coll Cardiol. 2017;70(6):776–803. doi:10.1016/j.jacc.2017.04.02528461007
   PubMed Web of Science ®Google Scholar
• HildebrandtP, CollinsonPO. Amino-terminal Pro–B-type natriuretic peptide testing to assist the diagnostic evaluation of heart failure in symptomatic primary care patients. Am J Cardiol. 2008;101(3, Supplement):S25–S28. doi:10.1016/j.amjcard.2007.11.016
   PubMed Web of Science ®Google Scholar
• MarcunR, SusticA, BrguljanPM, et al. Cardiac biomarkers predict outcome after hospitalisation for an acute exacerbation of chronic obstructive pulmonary disease. Int J Cardiol. 2012;161(3):156–159. doi:10.1016/j.ijcard.2012.05.04422668800
   PubMed Web of Science ®Google Scholar
• ChangCL, RobinsonSC, MillsGD, et al. Biochemical markers of cardiac dysfunction predict mortality in acute exacerbations of COPD. Thorax. 2011;66(9):764–768. doi:10.1136/thx.2010.15533321474497
   PubMed Web of Science ®Google Scholar
• HoisethAD, OmlandT, HagveTA, BrekkePH, SoysethV. NT-proBNP independently predicts long term mortality after acute exacerbation of COPD - a prospective cohort study. Respir Res. 2012;13(1):97. doi:10.1186/1465-9921-13-9723107284
   PubMed Web of Science ®Google Scholar
• PervezMO, WintherJA, BrynildsenJ, et al. Prognostic and diagnostic significance of mid-regional pro-atrial natriuretic peptide in acute exacerbation of chronic obstructive pulmonary disease and acute heart failure: data from the ACE 2 Study. Biomarkers. 2018;23(7):654–663. doi:10.1080/1354750X.2018.147425829733687
   PubMed Web of Science ®Google Scholar
• AdrishM, NannakaV, CanoE, BajantriB, Diaz-FuentesG. Significance of NT-pro-BNP in acute exacerbation of COPD patients without underlying left ventricular dysfunction. Int J Chron Obstruct Pulmon Dis. 2017;12:1183–1189. doi:10.2147/COPD28458528
   PubMed Web of Science ®Google Scholar
• VestboJ, HurdSS, AgustiAG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013;187(4):347–365. doi:10.1164/rccm.201204-0596PP22878278
   PubMed Web of Science ®Google Scholar
• HuG, WuY, ZhouY, et al. Prognostic role of D-dimer for in-hospital and 1-year mortality in exacerbations of COPD. Int J Chron Obstruct Pulmon Dis. 2016;11(1):2729–2736. doi:10.2147/COPD27843309
   PubMed Web of Science ®Google Scholar
• MouldR, HerbertD. Introductory medical statistics (Third Edition). Med Phys. 1999;26:664–665. doi:10.1118/1.598568
   Google Scholar
• PavasiniR, TavazziG, BiscagliaS, et al. Amino terminal pro brain natriuretic peptide predicts all-cause mortality in patients with chronic obstructive pulmonary disease: systematic review and meta-analysis. Chron Respir Dis. 2017;14(2):117–126. doi:10.1177/147997231667439327956645
   PubMed Web of Science ®Google Scholar
• StolzD, BreidthardtT, Christ-CrainM, et al. Use of B-type natriuretic peptide in the risk stratification of acute exacerbations of COPD. Chest. 2008;133(5):1088–1094. doi:10.1378/chest.07-195918339792
   PubMed Web of Science ®Google Scholar
• ChiSY, KimEY, BanHJ, et al. Plasma N-terminal pro-brain natriuretic peptide: a prognostic marker in patients with chronic obstructive pulmonary disease. Lung. 2012;190(3):271–276. doi:10.1007/s00408-011-9363-722246552
   PubMed Web of Science ®Google Scholar
• van GestelYR, GoeiD, HoeksSE, et al. Predictive value of NT-proBNP in vascular surgery patients with COPD and normal left ventricular systolic function. COPD. 2010;7(1):70–75. doi:10.3109/1541255090349947220214466
   PubMedGoogle Scholar
• MacchiaA, RodriguezMJ, KleinertM, et al. Unrecognised ventricular dysfunction in COPD. Eur Respir J. 2012;39(1):51–58. doi:10.1183/09031936.0004441121700606
   PubMed Web of Science ®Google Scholar
• MedinaAM, MartelesMS, SaizEB, et al. Prognostic utility of NT-proBNP in acute exacerbations of chronic pulmonary diseases. Eur J Intern Med. 2011;22(2):167–171. doi:10.1016/j.ejim.2010.12.00221402247
   PubMed Web of Science ®Google Scholar
• Dunham-SnaryKJ, WuD, SykesEA, et al. Hypoxic pulmonary vasoconstriction: from molecular mechanisms to medicine. Chest. 2017;151(1):181–192. doi:10.1016/j.chest.2016.09.00127645688
   PubMed Web of Science ®Google Scholar
• OzdemirelTS, UlasliSS, YetisB, KaracaglarE, BayraktarN, UlubayG. Effects of right ventricular dysfunction on exercise capacity and quality of life and associations with serum NT-proBNP levels in COPD: an observational study. Anadolu Kardiyol Derg. 2014;14(4):370–377. doi:10.5152/akd.01424818627
   PubMedGoogle Scholar
• LeeMH, ChangCL, DaviesAR, DavisM, HancoxRJ. Cardiac dysfunction and N-terminal pro-B-type natriuretic peptide in exacerbations of chronic obstructive pulmonary disease. Intern Med J. 2013;43(5):595–598. doi:10.1111/imj.1211223668272
   PubMed Web of Science ®Google Scholar